2741 - 2750 of 9148 Results
Title
Year
-
OPENTitle: In vivo detection of lateral–ventral tier nigral degeneration in Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 5Start Page: 2627End Page: 2634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23547Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23547Citation Count: 52
-
OPENTitle: 17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/969418Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/969418.pdfCitation Count: 12
-
OPENTitle: Replication of a Novel Parkinson's Locus in a European Ancestry PopulationJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1689End Page: 1695Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28546Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28546Citation Count: 19
-
OPENTitle: Systematic Optimization of Long Gradient Chromatography Mass Spectrometry for Deep Analysis of Brain ProteomeJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 14Issue #: 2Start Page: 829End Page: 838Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/pr500882hBest OA location URL: https://pubs.acs.org/doi/pdf/10.1021/pr500882hCitation Count: 105
-
OPENTitle: Single Molecule Fingerprinting Reveals Different Amplification Properties of α-Synuclein Oligomers and Preformed Fibrils in Seeding AssayJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 7Start Page: 883End Page: 896Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.1c00553Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.1c00553Citation Count: 19
- PubMedMetaTool: Automated metadata extraction from PubMed using Python for bibliometric analysis2025OPENTitle: PubMedMetaTool: Automated metadata extraction from PubMed using Python for bibliometric analysisJournal Name: Software ImpactsPublisher: Elsevier BVVol: 24Issue #:Start Page: 100766End Page: 100766Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.simpa.2025.100766Best OA location URL: https://doi.org/10.1016/j.simpa.2025.100766Citation Count: 2
- Singing in groups for Parkinson's disease (SING-PD): A pilot study of group singing therapy for PD-related voice/speech disorders2012RESTRICTEDTitle: Singing in groups for Parkinson's disease (SING-PD): A pilot study of group singing therapy for PD-related voice/speech disordersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 5Start Page: 548End Page: 552Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.02.009Citation Count: 72
-
OPENTitle: Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MSJournal Name: Clinical BiochemistryPublisher: Elsevier BVVol: 72Issue #:Start Page: 7End Page: 14Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.clinbiochem.2019.05.006Best OA location URL: https://doi.org/10.1016/j.clinbiochem.2019.05.006Citation Count: 47
-
OPENTitle: The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriersJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 2Start Page: 291End Page: 299Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x241310722Best OA location URL: https://doi.org/10.1177/1877718x241310722Citation Count: 11
-
OPENTitle: Development of cannabinoid-based therapies for Parkinson’s disease: emphasis on targeting cannabinoid receptors as CB2, PPAR-γ and GPR55 receptorsJournal Name: Molecular Neurodegeneration AdvancesPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s44477-025-00016-7Best OA location URL: https://doi.org/10.1186/s44477-025-00016-7Citation Count: 0